Welcome to our dedicated page for Metropolitan Bank SEC filings (Ticker: MCB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Metropolitan Bank Holding Corp. filings document the public-company disclosures of a New York bank holding company and the parent of Metropolitan Commercial Bank. Form 8-K reports cover results of operations, Regulation FD presentations, dividend actions, material agreements, registered common-stock offering activity and other corporate events tied to the company’s NYSE-listed common stock.
Proxy and annual-meeting filings describe board elections, shareholder voting matters, governance practices and executive-compensation disclosures. The filing record also includes disclosures on bank capital, commercial lending and credit, deposit verticals, EB-5 financial solutions, technology initiatives, risk factors and the regulatory context for a New York State chartered commercial bank that is a Federal Reserve member and FDIC-insured institution.
Metropolitan Bank Holding Corp (NYSE:MCB) submitted a routine Form 4 reporting that director Robert C. Patent sold 2,000 shares of common stock on June 18 2025 at an average price of $65.606, generating proceeds of roughly $131 thousand.
After the transaction, Patent retains 79,183 shares in direct ownership and a combined 86,829 shares held indirectly through a partnership (69,004 shares), a profit-sharing plan (14,445 shares) and a power-of-attorney arrangement over a sibling’s account (3,380 shares). The sale represents about 2.5 percent of his directly-held stake and does not materially change his overall economic exposure to the company.
Metropolitan Bank Holding (NYSE: MCB) submitted a routine Form 144 on 29 June 2025 disclosing a proposed insider sale of 5,000 common shares. The shares were acquired on 03 March 2021 via restricted-stock vesting as compensation and carry an aggregate market value of roughly $325,126. The planned trade, to be executed through Fidelity Brokerage, is slated for on-or-about 20 June 2025 on the NYSE. The notice states that approximately 10.66 million shares are outstanding. No other insider sales were reported during the last three months and no additional business or financial information was included.